Meet with us at ISoP ACoP 2026!
Join Premier Research at the ISoP American Conference on Pharmacometrics (ACoP), the leading event for model-informed drug development, quantitative clinical pharmacology, and pharmacometrics. Connect with our experts to discuss innovative approaches that support smarter, faster clinical development.
Our multidisciplinary team partners with biotechnology and pharmaceutical organizations across clinical pharmacology, pharmacometrics, biometrics, regulatory strategy, and clinical operations to help optimize development programs from preclinical activities to first-in-human studies and pivotal trials.
Featured Presentations:
Hear from our modeling experts across four poster presentations exploring the application of pharmacometric and PK/PD approaches to real-world development and regulatory challenges.
- Using Pharmacokinetic Modeling to Support Waiver for a Higher Dose for a New Oral Tablet Under the US FDA 505(b)(2) NDA Pathway
- Abstract ID: 2405727
- Exposure–Response Modeling of QT Prolongation Using Concentration–QT Analysis: Methodology and Regulatory Interpretation
- Abstract ID: 2405746
- Using Item Response Theory to Support PK/PD Bridging of a Transdermal Patch Under the US FDA 505(b)(2) NDA Pathway
- Abstract ID: 2405643
- A Semi-Mechanistic Translational PK/PD Model Integrating Plasma, CSF, and Brain Exposure Using Sparse Clinical Data
- Abstract ID: 2405675
On-Site
- Angelean Hendrix, Vice President, Pharmacometrics and MIDD
- Agnieszka Marcinowicz, Clinical Pharmacology Senior Director
- Jayesh Patel, Principal Scientist, Pharmacokinetics
- Isaac Asante, Principal Scientist, Pharmacology
- Nicholas Allen, Senior Director, Business Development
Fill out the form above to schedule a meeting with our on-site team.
Connect with our experts to explore how model-informed drug development can strengthen decision-making across your development program.
